Hit enter to search or ESC to close
NuView Life SciencesNuView Life SciencesNuView Life SciencesNuView Life Sciences
  • Home
  • About Us
    • Mission
    • Leadership
      • Management Team
      • Directors
      • Clinical Collaborators
  • Diagnostics
    • In Vivo Diagnostics
    • In Vitro Diagnostics
    • Theranostics Applications
    • Why Research for New Diagnostics?
  • Publications
  • News
    • NuView Life Sciences in the News
    • Press Releases
  • Contact Us
NuView Life Sciences
Category

Press Releases

Feb 08
Love0

Oncology Firm Develops Test for Potential Pediatric Cancers Diagnoses

By Karla Jo Helms Press Releases

Modern cancer diagnosis tests and treatments are based on what works for adults. A new technology, NV-VPAC1(™), may help doctors better and more accurately diagnose…

Read More
Nov 16
Love0

NuView Life Sciences Develops New Theranostics Approach to Offset High Cost of Cancer Diagnosis, Treatment

By Karla Jo Helms News, Press Releases

The high cost of diagnosing and treating cancer—in addition to the prescription drugs and therapies associated with the disease—is bankrupting hard-working Americans, who cannot afford…

Read More
Aug 17
Love0

NuView NV-VPAC1 Uniquely Positioned to Find the Overexpression of Specific Receptors Appearing only on the Surface of Malignant Cells for Early Cancer Diagnosis

By Karla Jo Helms Press Releases

Cancer diagnosis and treatment need to be improved—and theranostics technology is working to bring a solution to market. NuView Life Sciences is focused on a…

Read More
Aug 04
Love0

NuView Life Sciences Secures $90 Million Capital Commitment from Global Emerging Markets for Development of NV-VPAC1™ Cancer Portfolio

By Karla Jo Helms Press Releases

PARK CITY, Utah (PRWEB)August 03, 2020 NuView Life Sciences, Inc. announced that it has signed an agreement with GEM Global Yield LLC SCS, a Luxembourg-based…

Read More
Aug 13
Love1

New Guidelines Recommend More Frequent Breast Cancer Screening, But False Positive Results Persist

By Karla Jo Helms Press Releases

PARK CITY, Utah, August 13, 2019 /PRNewswire-PRWeb/ — The American Society of Breast Surgeons recently announced new cancer screening guidelines that are designed to help…

Read More
Mar 13
Love0

Binding Cell Receptors Key to New Prostate Cancer Diagnostic Test from NuView Life Sciences

By Karla Jo Helms Press Releases

A recent study validating urine diagnosis for cancer cell receptors in prostate cancer is eclipsing traditional methodology and warrants further steps toward FDA approval says…

Read More
Aug 29
Love1

Development of Precision Cancer Diagnostics Continues Amid Booming Tumor Profiling Market

By Karla Jo Helms Press Releases

The cancer (tumor) profiling market is expected to grow at a CAGR of 19.1% over the next four years. This growth directly reflects the public’s…

Read More
Aug 08
Love0

Emerging Technology Means Shift Needed Towards Diagnostic Testing Markets

By Karla Jo Helms Press Releases

Cancer diagnostics technology continues to evolve, with emerging science based in precision medicine beginning to dominate the industry. Even though global markets are primarily focused…

Read More
Jul 07
Love0

NuView Life Sciences Developing Solution to Help Offset Cancer Diagnostic and Treatment Costs

By Karla Jo Helms Press Releases

As cancer rates continue to rise, patients increasingly bear the brunt of both the financial and emotional costs related to their diagnosis. In an effort…

Read More
Jun 07
Love0

Genetic Testing Paving the Way for Precision Medicine-Based Cancer Treatment

By Karla Jo Helms Press Releases

While genetic testing has been used for years to diagnose cancer, it is now finding new application in the identification of cancerous mutations that will…

Read More
1 2 Next

Categories

  • News
  • NuView Life Sciences in the News
  • Press Releases

Recent Posts

  • Oncology Firm Develops Test for Potential Pediatric Cancers Diagnoses
  • Delfi Diagnostics reels in $100M for blood-based cancer test
  • Radiopharmaceuticals Are Showing Promise as the Next Generation of Cancer Treatment
  • NuView Life Sciences Develops New Theranostics Approach to Offset High Cost of Cancer Diagnosis, Treatment
  • Radiopharmaceuticals Gain Traction for Cancer Theranostics Potential

Archives

  • February 2021
  • January 2021
  • November 2020
  • August 2020
  • June 2020
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • March 2019
  • November 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016

NuView Life Sciences is a clinical stage oncology company addressing unmet medical needs.

Read More

Contact Address

NuView Life Sciences, Inc
1389 Center Drive, Suite 200
Park City, Utah 84098

Office: 435.647.9758 

Contact us:
admin@nuviewlifesciences.com

Media inquiries:
Kaden Haig
khaig@jotopr.com

The most recent press

  • Oncology Firm Develops Test for Potential Pediatric Cancers Diagnoses February 8, 2021
  • NuView Life Sciences Develops New Theranostics Approach to Offset High Cost of Cancer Diagnosis, Treatment November 16, 2020

Quick Links

  • Home
  • About Us
  • Products
  • News

© 2021 NuView Life Sciences. Terms of Use

  • Home
  • About Us
    • Mission
    • Leadership
      • Management Team
      • Directors
      • Clinical Collaborators
  • Diagnostics
    • In Vivo Diagnostics
    • In Vitro Diagnostics
    • Theranostics Applications
    • Why Research for New Diagnostics?
  • Publications
  • News
    • NuView Life Sciences in the News
    • Press Releases
  • Contact Us